Kindred Biosciences (KIN) Tops Q2 EPS by 3c

Kindred Biosciences (NASDAQ: KIN) reported Q2 EPS of ($0.29), $0.03 better than the analyst estimate of ($0.32). R

For earnings history and earnings-related data on Kindred Biosciences (KIN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M